30
views
0
recommends
+1 Recommend
1 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Transmission Dynamics of COVID-19 Outbreaks Associated with Child Care Facilities — Salt Lake City, Utah, April–July 2020

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          On September 11, 2020, this report was posted online as an MMWR Early Release. Reports suggest that children aged ≥10 years can efficiently transmit SARS-CoV-2, the virus that causes coronavirus disease 2019 (COVID-19) ( 1 , 2 ). However, limited data are available on SARS-CoV-2 transmission from young children, particularly in child care settings ( 3 ). To better understand transmission from young children, contact tracing data collected from three COVID-19 outbreaks in child care facilities in Salt Lake County, Utah, during April 1–July 10, 2020, were retrospectively reviewed to explore attack rates and transmission patterns. A total of 184 persons, including 110 (60%) children had a known epidemiologic link to one of these three facilities. Among these persons, 31 confirmed COVID-19 cases occurred; 13 (42%) in children. Among pediatric patients with facility-associated confirmed COVID-19, all had mild or no symptoms. Twelve children acquired COVID-19 in child care facilities. Transmission was documented from these children to at least 12 (26%) of 46 nonfacility contacts (confirmed or probable cases). One parent was hospitalized. Transmission was observed from two of three children with confirmed, asymptomatic COVID-19. Detailed contact tracing data show that children can play a role in transmission from child care settings to household contacts. Having SARS-CoV-2 testing available, timely results, and testing of contacts of persons with COVID-19 in child care settings regardless of symptoms can help prevent transmission. CDC guidance for child care programs recommends the use of face masks, particularly among staff members, especially when children are too young to wear masks, along with hand hygiene, frequent cleaning and disinfecting of high-touch surfaces, and staying home when ill to reduce SARS-CoV-2 transmission ( 4 ). Contact tracing* data collected during April 1–July 10, 2020 through Utah’s National Electronic Disease Surveillance System (EpiTrax) were used to retrospectively construct transmission chains from reported COVID-19 child care facility outbreaks, defined as two or more laboratory-confirmed COVID-19 cases within 14 days among staff members or attendees at the same facility. EpiTrax maintains records of epidemiologic linkage between index patients and contacts (defined as anyone who was within 6 feet of a person with COVID-19 for at least 15 minutes ≤2 days before the patient’s symptom onset) and captures data on demographic characteristics, symptoms, exposures, testing, and the monitoring/isolation period. A confirmed case was defined as receipt of a positive SARS-CoV-2 real-time reverse transcription–polymerase chain reaction (RT-PCR) test result. A probable case was an illness with COVID-19–compatible symptoms, † epidemiologically linked to the outbreak, but with no laboratory testing. For this report, the index case was defined as the first confirmed case identified in a person at the child care facility, and the primary case was defined as the earliest confirmed case linked to the outbreak. Pediatric patients were aged <18 years; adults were aged ≥18 years. Persons with confirmed or probable child care facility–associated COVID-19 were required to isolate upon experiencing symptoms or receiving a positive SARS-CoV-2 test result. Contacts were required to quarantine for 14 days after contact with a person with a confirmed case. Facility attack rates were calculated by including patients with confirmed and probable facility-associated cases (including the index patient) in the numerator and all facility staff members and attendees in the denominator. Overall attack rates include facility-associated cases (including the index case) and nonfacility contact (household and nonhousehold) cases in the numerator and all facility staff members and attendees and nonfacility contacts in the denominator; the primary case and cases linked to the primary case are excluded. During April 1–July 10, Salt Lake County identified 17 child care facilities (day care facilities and day camps for school-aged children; henceforth, facilities) with at least two confirmed COVID-19 cases within a 14-day period. This report describes outbreaks in three facilities that experienced possible transmission within the facility and had complete contact investigation information. A total of 184 persons, including 74 (40%) adults (median age = 30 years; range = 19–78 years) and 110 (60%) children (median age = 7 years; range = 0.2–16 years), had a known epidemiologic link to one of these three facilities with an outbreak; 54% were female and 40% were male. Among these persons, 31 confirmed COVID-19 cases occurred (Table 1); 18 (58%) cases occurred in adults and 13 (42%) in children. Among all contacts, nine confirmed and seven probable cases occurred; the remaining 146 contacts had either negative test results (50; 27%), were asymptomatic and were not tested (94; 51%) or had unknown symptoms and testing information (2; 1%). TABLE 1 Characteristics of all staff members, attendees, and their contacts associated with COVID-19 outbreaks at three child care facilities — Salt Lake County, Utah, April 1–July 10, 2020 Characteristic No. (% with available information) Total* Adult* Pediatric* Facility staff members, attendees, and contacts 184 (100) 74 (100) 110 (100) Age, yrs, median (range)† 9 (0.2–78) 30 (19–78) 7 (0.2–16) Sex Female 100 (54) 42 (57) 58 (53) Male 74 (40) 31 (42) 43 (39) Unavailable 10 (5) 1 (1) 9 (8) Linkage to facility Facility staff member or attendee 101 (55) 18 (24) 83 (75) Nonfacility contact§ 83 (45) 56 (76) 27 (25) Confirmed¶ COVID-19 cases Total 31 (17) 18 (24) 13 (12) Symptomatic 24 (13) 15 (24) 9 (8) Index case at facility 3 (2) 3 (4) 0 (–) Asymptomatic 4 (2) 0 (–) 4 (4) Probable¶ COVID-19 cases 7 (4) 5 (7) 2 (2) Contacts§ Total 146 (79) 51 (60) 95 (86) Contacts with a negative test result 50 (27) 27 (36) 23 (21) Asymptomatic contacts, not tested 94 (51) 22 (30) 72 (65) Contacts with unknown symptoms and testing 2 (1) 2 (3) 0 (—) Abbreviation: COVID-19 = coronavirus disease 2019. * Does not include two persons with primary cases or their six contacts; two adult contacts had unknown symptom and testing information. Percent is calculated as a percentage of the total. † Age data were missing for 11 contacts. § Includes pediatric and adult household and nonhousehold contacts. ¶ A confirmed case was defined as a positive SARS-CoV-2 reverse transcription–polymerase chain reaction test result. A probable case was an illness with symptoms consistent with COVID-19 and linked to the outbreak but without laboratory testing. Among the 101 facility staff members and attendees, 22 (22%) confirmed COVID-19 cases (10 adult and 12 pediatric) were identified (Table 2), accounting for 71% of the 31 confirmed cases; the remaining nine (29%) cases occurred in contacts of staff members or attendees. Among the 12 facility-associated pediatric patients with confirmed COVID-19, nine had mild symptoms, and three were asymptomatic. Among 83 contacts of these 12 pediatric patients, 46 (55%) were nonfacility contacts, including 12 (26%) who had confirmed (seven) and probable (five) COVID-19. Six of these cases occurred in mothers and three in siblings of the pediatric patients. Overall, 94 (58%) of 162 contacts of persons with facility-associated cases had no symptoms of COVID-19 and were not tested. Staff members at two of the facilities had a household contact with confirmed or probable COVID-19 and went to work while their household contact was symptomatic. These household contacts represented the primary cases in their respective outbreaks. TABLE 2 Classification of contacts with known linkage to facility-associated confirmed adult and pediatric cases* at three child care facilities — Salt Lake County, Utah, April 1–July 10, 2020 Classification No. (%) Total† Adult† Pediatric Facility A B C COVID-19 cases at facilities§ 22 10 12 2 5 15 Contacts ¶ linked to cases at facilities 162 79 83 25 28 109 Contacts¶ with confirmed COVID-19 9 (6) 2 (3) 7 (8) 0 (—) 4 (14) 5 (5) Contacts¶ with probable COVID-19 7 (4) 2 (3) 5 (6) 0 (—) 3 (11) 4 (4) Contacts¶ with negative test results 50 (31) 25 (32) 25 (30) 3 (12) 13 (46) 34 (31) Asymptomatic contacts, not tested 94 (58) 48 (61) 46 (55) 20 (80) 8 (29) 66 (61) Contacts with unknown symptoms and testing 2 (1) 2 (3) 0 (—) 2 (1) 0 (—) 0 (—) Interval (days) Facility case onset to contact onset, median (range)** 4 (1–8) 6 (4–6) 3 (1–8) 1 (1–1) 4.5 (1–6) 4 (3–8) Facility case onset to testing, median (range)†† 2.5 (0–6) 1 (0–4) 4 (1–6) 2.5 (1–4) 1 (0–3) 2 (0–10) Abbreviation: COVID-19 = coronavirus disease 2019. * A confirmed case was defined as a positive SARS-CoV-2 reverse transcription–polymerase chain reaction test result. A probable case was an illness with symptoms consistent with COVID-19 and linked to the outbreak but without laboratory testing. † A positive adult case linked to facility attendee from Facility B is included because they were a staff member. § Includes index cases. ¶ Includes pediatric and adult household and nonhousehold contacts. ** For cases in persons who were asymptomatic, onset for contact is date of receipt of positive test result. †† Does not include three pediatric facility cases in persons who were asymptomatic who did not have symptom onset dates. Facility A Outbreak Facility A, which had been deemed an essential business and had not closed before the outbreak occurred, required daily temperature and symptom screening for the 12 staff members and children and more frequent cleaning and disinfection; staff members were required to wear masks. Two COVID-19 cases in staff members were associated with facility A (Figure). The index case at facility A (patient A1) occurred in a staff member who reported symptom onset on April 2, self-isolated on April 3, and had a positive SARS-CoV-2 RT-PCR test result from a nasopharyngeal (NP) swab specimen obtained on April 6. Three days after patient A1’s symptom onset, a second staff member (patient A2) experienced symptoms and had a positive SARS-CoV-2 test result 1 day later. Ten facility contacts (nine children aged 1–5 years and one staff member) remained asymptomatic during the monitoring period and were not tested. The last reported exposure at facility A was on April 3, when the facility closed. Among the 15 nonfacility contacts of patients A1 and A2 (including four children aged 1–13 years), 10 remained asymptomatic throughout their monitoring period and were not tested, and three received negative test results; the symptom and testing information for two nonfacility contacts was unknown. The primary patient, a household contact of the index patient, reported symptom onset 9 days before symptom onset in patient A1 and received a positive SARS-CoV-2 test result from an NP specimen collected on April 6. The facility attack rate (excluding the primary case) for facility A was 17% (two of 12) and was 7% overall (including contacts) (two of 27). FIGURE Transmission chains* and attack rates † , § in three COVID-19 child care facility outbreaks ¶ ,**,†† — Salt Lake County, Utah, April 1– July 10, 2020 Abbreviation: COVID-19 = coronavirus disease 2019. * Transmission chains developed using Microbe Trace software. https://www.biorxiv.org/content/10.1101/2020.07.22.216275v1. † Facility attack rates include index cases and all facility staff members and attendees. § Overall attack rates include all facility staff members and attendees (including the index case) and nonfacility contacts (household and nonhousehold). It does not include the primary case or the cases linked to the primary case. ¶ A confirmed case was defined as a positive SARS-CoV-2 reverse transcription–polymerase chain reaction test result. A probable case was an illness with symptoms consistent with COVID-19 and linked to the outbreak but without laboratory testing. ** The index case was defined as the earliest confirmed case in a person at the child care facility. †† A primary case was defined as the earliest confirmed case linked to the outbreak. The figure is a diagram of a transmission chain showing links between contacts and cases and indicating attacks rates in three COVID-19 outbreaks in child care facilities in Salt Lake County, Utah, during April 1–July 10, 2020. Facility B Outbreak Facility B was closed during March 13–May 4. Upon reopening, temperatures of the five staff members and children were checked daily, and more frequent cleaning was conducted; only staff members were required to wear masks. Five COVID-19 cases in three staff members and two children were associated with facility B (Figure). The index case (B1) occurred in a staff member who was tested on May 31 while presymptomatic (because of a household contact with COVID-19) and received a SARS-CoV-2-positive test result; patient B1 experienced mild COVID-19 symptoms on June 3 and last worked on May 29. A second staff member (patient B2), experienced symptoms on June 8, was tested, and received a positive test result 2 days later. Patients B3 and B4, children aged 8 months and 8 years, respectively, experienced mild signs and symptoms (fever, fatigue, runny nose) 7 and 8 days, respectively, after symptom onset in patient B2; both children were tested and received positive test results the day after their symptoms commenced. A third staff member, patient B5, experienced symptoms 9 days after symptoms occurred in patient B4, was tested, and received a positive test result 1 day later. The two children likely transmitted SARS-CoV-2 to their contacts including two confirmed cases (in one child’s mother and father, both symptomatic 2 and 3 days, respectively, following the child’s illness onset) and three probable cases (in two adults, including one mother and a child). The index patient (B1) was a household contact of the primary patient who had symptom onset May 26, was tested on May 29, and received a positive SARS-CoV-2 test result. The facility attack rate for facility B was 100% (five of five) and the overall attack rate was 36% (12 of 33). Facility C Outbreak Facility C was closed during March 13–June 17. Upon reopening, the facility requested that 84 staff members and children check their temperature and monitor their symptoms daily; masks were not required for staff members or children. Fifteen COVID-19 cases (in five staff members and 10 children) were associated with facility C (Figure). Two staff members and two students reported symptoms on June 24 and self-isolated. The index case occurred in a staff member (patient C1), who had a positive test result from an NP specimen obtained on June 25. The second staff member, patient C2, was tested 2 days later and received a positive SARS-CoV-2 test result, and the two students (aged 7 and 8 years) were tested on June 28 and 29, respectively and received positive test results. Over the subsequent 8 days, an additional eight students (aged 6–10 years), three of whom were asymptomatic, and three staff members (all symptomatic) received positive SARS-CoV-2 test results. Pediatric patients at the facility likely transmitted SARS-CoV-2 to their contacts, including five confirmed cases in household contacts (three mothers, one aunt, and one child) and two probable household cases (one mother and one child). Symptoms developed 3 and 5 days following the child’s illness onset when onset date was known. One mother who was presumably infected by her asymptomatic child was subsequently hospitalized. Among the seven cases in symptomatic children, fever was the most common sign, followed by symptoms of headache and sore throat. The source for this cluster was not identified. The facility attack rate for facility C was 18% (15 of 84) and the overall attack rate was 19% (24 of 124). Discussion Analysis of contact tracing data in Salt Lake County, Utah, identified outbreaks of COVID-19 in three small to large child care facilities linked to index cases in adults and associated with transmission from children to household and nonhousehold contacts. In these three outbreaks, 54% of the cases linked to the facilities occurred in children. Transmission likely occurred from children with confirmed COVID-19 in a child care facility to 25% of their nonfacility contacts. Mitigation strategies § could have helped limit SARS-CoV-2 transmission in these facilities. To help control the spread of COVID-19, the use of masks is recommended for persons aged ≥2 years. ¶ Although masks likely reduce the transmission risk ( 5 ), some children are too young to wear masks but can transmit SARS-CoV-2, as was seen in facility B when a child aged 8 months transmitted SARS-CoV-2 to both parents. The findings in the report are subject to at least three limitations. First, guidance for contact tracing methodology changed during the pandemic and could have resulted in differences in data collected over time. Second, testing criteria initially included only persons with typical COVID-19 signs and symptoms of fever, cough, and shortness of breath, which could have led to an underestimate of cases and transmission. Finally, because the source for the outbreak at facility C was unknown, it is possible that cases associated with facility C resulted from transmission outside the facility. COVID-19 is less severe in children than it is in adults ( 6 , 7 ), but children can still play a role in transmission ( 8 , 9 ). The infected children exposed at these three facilities had mild to no symptoms. Two of three asymptomatic children likely transmitted SARS-CoV-2 to their parents and possibly to their teachers. Having SARS-CoV-2 testing available, timely results, and testing of contacts of patients in child care settings regardless of symptoms can help prevent transmission and provide a better understanding of the role played by children in transmission. Findings that staff members worked while their household contacts were ill with COVID-19–compatible symptoms support CDC guidance for child care programs recommendations that staff members and attendees quarantine and seek testing if household members are symptomatic ( 4 ). This guidance also recommends the use of face masks, particularly among staff members, especially when children are too young to wear masks, along with hand hygiene, frequent cleaning and disinfecting of high-touch surfaces, and staying home when ill to reduce SARS-CoV-2 transmission. Summary What is already known about this topic? Children aged ≥10 years have been shown to transmit SARS-CoV-2 in school settings. What is added by this report? Twelve children acquired COVID-19 in child care facilities. Transmission was documented from these children to at least 12 (26%) of 46 nonfacility contacts (confirmed or probable cases). One parent was hospitalized. Transmission was observed from two of three children with confirmed, asymptomatic COVID-19. What are the implications for public health practice? SARS-CoV-2 Infections among young children acquired in child care settings were transmitted to their household members. Testing of contacts of laboratory-confirmed COVID-19 cases in child care settings, including children who might not have symptoms, could improve control of transmission from child care attendees to family members.

          Related collections

          Most cited references8

          • Record: found
          • Abstract: found
          • Article: not found

          Epidemiological Characteristics of 2143 Pediatric Patients With 2019 Coronavirus Disease in China

          To identify the epidemiological characteristics and transmission patterns of pediatric patients with the 2019 novel coronavirus disease (COVID-19) in China.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: found
            Is Open Access

            Coronavirus Disease 2019 in Children — United States, February 12–April 2, 2020

            On April 6, 2020, this report was posted online as an MMWR Early Release. As of April 2, 2020, the coronavirus disease 2019 (COVID-19) pandemic has resulted in >890,000 cases and >45,000 deaths worldwide, including 239,279 cases and 5,443 deaths in the United States ( 1 , 2 ). In the United States, 22% of the population is made up of infants, children, and adolescents aged * Includes infants, children, and adolescents. † Excludes 23 cases in children aged <18 years with missing report date. § Date of report available starting February 24, 2020; reported cases include any with onset on or after February 12, 2020. The figure is a combination epidemiological curve and line graph showing 2,549 cases of COVID-19 in children aged <18 years in the United States, by date reported to CDC during February 24–April 2, 2020. Among all 2,572 COVID-19 cases in children aged <18 years, the median age was 11 years (range 0–17 years). Nearly one third of reported pediatric cases (813; 32%) occurred in children aged 15–17 years, followed by those in children aged 10–14 years (682; 27%). Among younger children, 398 (15%) occurred in children aged <1 year, 291 (11%) in children aged 1–4 years, and 388 (15%) in children aged 5–9 years. Among 2,490 pediatric COVID-19 cases for which sex was known, 1,408 (57%) occurred in males; among cases in adults aged ≥18 years for which sex was known, 53% (75,450 of 143,414) were in males. Among 184 (7.2%) cases in children aged <18 years with known exposure information, 16 (9%) were associated with travel and 168 (91%) had exposure to a COVID-19 patient in the household or community. Data on signs and symptoms of COVID-19 were available for 291 of 2,572 (11%) pediatric cases and 10,944 of 113,985 (9.6%) cases among adults aged 18–64 years (Table). Whereas fever (subjective or documented), cough, and shortness of breath were commonly reported among adult patients aged 18–64 years (93% reported at least one of these), these signs and symptoms were less frequently reported among pediatric patients (73%). Among those with known information on each symptom, 56% of pediatric patients reported fever, 54% reported cough, and 13% reported shortness of breath, compared with 71%, 80%, and 43%, respectively, reporting these signs and symptoms among patients aged 18–64 years. Myalgia, sore throat, headache, and diarrhea were also less commonly reported by pediatric patients. Fifty-three (68%) of the 78 pediatric cases reported not to have fever, cough, or shortness of breath had no symptoms reported, but could not be classified as asymptomatic because of incomplete symptom information. One (1.3%) additional pediatric patient with a positive test result for SARS-CoV-2 was reported to be asymptomatic. TABLE Signs and symptoms among 291 pediatric (age <18 years) and 10,944 adult (age 18–64 years) patients* with laboratory-confirmed COVID-19 — United States, February 12–April 2, 2020 Sign/Symptom No. (%) with sign/symptom Pediatric Adult Fever, cough, or shortness of breath† 213 (73) 10,167 (93) Fever§ 163 (56) 7,794 (71) Cough 158 (54) 8,775 (80) Shortness of breath 39 (13) 4,674 (43) Myalgia 66 (23) 6,713 (61) Runny nose¶ 21 (7.2) 757 (6.9) Sore throat 71 (24) 3,795 (35) Headache 81 (28) 6,335 (58) Nausea/Vomiting 31 (11) 1,746 (16) Abdominal pain¶ 17 (5.8) 1,329 (12) Diarrhea 37 (13) 3,353 (31) *Cases were included in the denominator if they had a known symptom status for fever, cough, shortness of breath, nausea/vomiting, and diarrhea. Total number of patients by age group: <18 years (N = 2,572), 18–64 years (N = 113,985). † Includes all cases with one or more of these symptoms. § Patients were included if they had information for either measured or subjective fever variables and were considered to have a fever if “yes” was indicated for either variable. ¶ Runny nose and abdominal pain were less frequently completed than other symptoms; therefore, percentages with these symptoms are likely underestimates. Information on hospitalization status was available for 745 (29%) cases in children aged <18 years and 35,061 (31%) cases in adults aged 18–64 years. Among children with COVID-19, 147 (estimated range = 5.7%–20%) were reported to be hospitalized, with 15 (0.58%–2.0%) admitted to an ICU (Figure 2). Among adults aged 18–64 years, the percentages of patients who were hospitalized (10%–33%), including those admitted to an ICU (1.4%–4.5%), were higher. Children aged <1 year accounted for the highest percentage (15%–62%) of hospitalization among pediatric patients with COVID-19. Among 95 children aged <1 year with known hospitalization status, 59 (62%) were hospitalized, including five who were admitted to an ICU. The percentage of patients hospitalized among those aged 1–17 years was lower (estimated range = 4.1%–14%), with little variation among age groups (Figure 2). FIGURE 2 COVID-19 cases among children* aged <18 years, among those with known hospitalization status (N = 745),† by age group and hospitalization status — United States, February 12–April 2, 2020 Abbreviation: ICU = intensive care unit. * Includes infants, children, and adolescents. † Number of children missing hospitalization status by age group: <1 year (303 of 398; 76%); 1–4 years (189 of 291; 65%); 5–9 years (275 of 388; 71%); 10–14 years (466 of 682; 68%); 15–17 years (594 of 813; 73%). The figure is a bar chart showing 745 U.S. COVID-19 cases among children aged <18 years with known hospitalization status, by age group and hospitalization status during February 12–April 2, 2020. Among 345 pediatric cases with information on underlying conditions, 80 (23%) had at least one underlying condition. The most common underlying conditions were chronic lung disease (including asthma) (40), cardiovascular disease (25), and immunosuppression (10). Among the 295 pediatric cases for which information on both hospitalization status and underlying medical conditions was available, 28 of 37 (77%) hospitalized patients, including all six patients admitted to an ICU, had one or more underlying medical condition; among 258 patients who were not hospitalized, 30 (12%) patients had underlying conditions. Three deaths were reported among the pediatric cases included in this analysis; however, review of these cases is ongoing to confirm COVID-19 as the likely cause of death. Discussion Among 149,082 U.S. cases of COVID-19 reported as of April 2, 2020, for which age was known, 2,572 (1.7%) occurred in patients aged <18 years. In comparison, persons aged <18 years account for 22% of the U.S. population ( 3 ). Although infants <1 year accounted for 15% of pediatric COVID-19 cases, they remain underrepresented among COVID-19 cases in patients of all ages (393 of 149,082; 0.27%) compared with the percentage of the U.S. population aged <1 year (1.2%) ( 3 ). Relatively few pediatric COVID-19 cases were hospitalized (5.7%–20%; including 0.58%–2.0% admitted to an ICU), consistent with previous reports that COVID-19 illness often might have a mild course among younger patients ( 4 , 5 ). Hospitalization was most common among pediatric patients aged <1 year and those with underlying conditions. In addition, 73% of children for whom symptom information was known reported the characteristic COVID-19 signs and symptoms of fever, cough, or shortness of breath. These findings are largely consistent with a report on pediatric COVID-19 patients aged <16 years in China, which found that only 41.5% of pediatric patients had fever, 48.5% had cough, and 1.8% were admitted to an ICU ( 4 ). A second report suggested that although pediatric COVID-19 patients infrequently have severe outcomes, the infection might be more severe among infants ( 5 ). In the current analysis, 59 of 147 pediatric hospitalizations, including five of 15 pediatric ICU admissions, were among children aged <1 year; however, most reported U.S. cases in infants had unknown hospitalization status. In this preliminary analysis of U.S. pediatric COVID-19 cases, a majority (57%) of patients were males. Several studies have reported a majority of COVID-19 cases among males ( 4 , 9 ), and an analysis of 44,000 COVID-19 cases in patients of all ages in China reported a higher case-fatality rate among men than among women ( 10 ). However, the same report, as well as a separate analysis of 2,143 pediatric COVID-19 cases from China, detected no substantial difference in the number of cases among males and females ( 5 , 10 ). Reasons for any potential difference in COVID-19 incidence or severity between males and females are unknown. In the present analysis, the predominance of males in all pediatric age groups, including patients aged <1 year, suggests that biologic factors might play a role in any differences in COVID-19 susceptibility by sex. The findings in this report are subject to at least four limitations. First, because of the high workload associated with COVID-19 response activities on local, state, and territorial public health personnel, a majority of pediatric cases were missing data on disease symptoms, severity, or underlying conditions. Data for many variables are unlikely to be missing at random, and as such, these results must be interpreted with caution. Because of the high percentage of missing data, statistical comparisons could not be conducted. Second, because many cases occurred only days before publication of this report, the outcome for many patients is unknown, and this analysis might underestimate severity of disease or symptoms that manifested later in the course of illness. Third, COVID-19 testing practices differ across jurisdictions and might also differ across age groups. In many areas, prioritization of testing for severely ill patients likely occurs, which would result in overestimation of the percentage of patients with COVID-19 infection who are hospitalized (including those treated in an ICU) among all age groups. Finally, this analysis compares clinical characteristics of pediatric cases (persons aged <18 years) with those of cases among adults aged 18–64 years. Severe COVID-19 disease appears to be more common among adults at the high end of this age range ( 6 ), and therefore cases in young adults might be more similar to those among children than suggested by the current analysis. As the number of COVID-19 cases continues to increase in many parts of the United States, it will be important to adapt COVID-19 surveillance strategies to maintain collection of critical case information without overburdening jurisdiction health departments. National surveillance will increasingly be complemented by focused surveillance systems collecting comprehensive case information on a subset of cases across various health care settings. These systems will provide detailed information on the evolving COVID-19 incidence and risk factors for infection and severe disease. More systematic and detailed collection of underlying condition data among pediatric patients would be helpful to understand which children might be at highest risk for severe COVID-19 illness. This preliminary examination of characteristics of COVID-19 disease among children in the United States suggests that children do not always have fever or cough as reported signs and symptoms. Although most cases reported among children to date have not been severe, clinicians should maintain a high index of suspicion for COVID-19 infection in children and monitor for progression of illness, particularly among infants and children with underlying conditions. However, these findings must be interpreted with caution because of the high percentage of cases missing data on important characteristics. Because persons with asymptomatic and mild disease, including children, are likely playing a role in transmission and spread of COVID-19 in the community, social distancing and everyday preventive behaviors are recommended for persons of all ages to slow the spread of the virus, protect the health care system from being overloaded, and protect older adults and persons of any age with serious underlying medical conditions. Recommendations for reducing the spread of COVID-19 by staying at home and practicing strategies such as respiratory hygiene, wearing cloth face coverings when around others, and others are available on CDC’s coronavirus website at https://www.cdc.gov/coronavirus/2019-ncov/prevent-getting-sick/prevention.html. Summary What is already known about this topic? Data from China suggest that pediatric coronavirus disease 2019 (COVID-19) cases might be less severe than cases in adults and that children (persons aged <18 years) might experience different symptoms than adults. What is added by this report? In this preliminary description of pediatric U.S. COVID-19 cases, relatively few children with COVID-19 are hospitalized, and fewer children than adults experience fever, cough, or shortness of breath. Severe outcomes have been reported in children, including three deaths. What are the implications for public health practice? Pediatric COVID-19 patients might not have fever or cough. Social distancing and everyday preventive behaviors remain important for all age groups because patients with less serious illness and those without symptoms likely play an important role in disease transmission.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Clinical and epidemiological features of 36 children with coronavirus disease 2019 (COVID-19) in Zhejiang, China: an observational cohort study

              Summary Background Since December, 2019, an outbreak of coronavirus disease 2019 (COVID-19) has spread globally. Little is known about the epidemiological and clinical features of paediatric patients with COVID-19. Methods We retrospectively retrieved data for paediatric patients (aged 0–16 years) with confirmed COVID-19 from electronic medical records in three hospitals in Zhejiang, China. We recorded patients' epidemiological and clinical features. Findings From Jan 17 to March 1, 2020, 36 children (mean age 8·3 [SD 3·5] years) were identified to be infected with severe acute respiratory syndrome coronavirus 2. The route of transmission was by close contact with family members (32 [89%]) or a history of exposure to the epidemic area (12 [33%]); eight (22%) patients had both exposures. 19 (53%) patients had moderate clinical type with pneumonia; 17 (47%) had mild clinical type and either were asymptomatic (ten [28%]) or had acute upper respiratory symptoms (seven [19%]). Common symptoms on admission were fever (13 [36%]) and dry cough (seven [19%]). Of those with fever, four (11%) had a body temperature of 38·5°C or higher, and nine (25%) had a body temperature of 37·5–38·5°C. Typical abnormal laboratory findings were elevated creatine kinase MB (11 [31%]), decreased lymphocytes (11 [31%]), leucopenia (seven [19%]), and elevated procalcitonin (six [17%]). Besides radiographic presentations, variables that were associated significantly with severity of COVID-19 were decreased lymphocytes, elevated body temperature, and high levels of procalcitonin, D-dimer, and creatine kinase MB. All children received interferon alfa by aerosolisation twice a day, 14 (39%) received lopinavir–ritonavir syrup twice a day, and six (17%) needed oxygen inhalation. Mean time in hospital was 14 (SD 3) days. By Feb 28, 2020, all patients were cured. Interpretation Although all paediatric patients in our cohort had mild or moderate type of COVID-19, the large proportion of asymptomatic children indicates the difficulty in identifying paediatric patients who do not have clear epidemiological information, leading to a dangerous situation in community-acquired infections. Funding Ningbo Clinical Research Center for Children's Health and Diseases, Ningbo Reproductive Medicine Centre, and Key Scientific and Technological Innovation Projects of Wenzhou.
                Bookmark

                Author and article information

                Journal
                MMWR Morb Mortal Wkly Rep
                MMWR Morb. Mortal. Wkly. Rep
                WR
                Morbidity and Mortality Weekly Report
                Centers for Disease Control and Prevention
                0149-2195
                1545-861X
                18 September 2020
                18 September 2020
                : 69
                : 37
                : 1319-1323
                Affiliations
                CDC COVID-19 Response Team; Salt Lake County Health Department, Utah; Utah Department of Health.
                Author notes
                Corresponding author: Cuc H. Tran, ywj0@ 123456cdc.gov .
                Article
                mm6937e3
                10.15585/mmwr.mm6937e3
                7498176
                32941418
                063d3da8-63ff-466d-a11e-e8d2e4bef06f

                All material in the MMWR Series is in the public domain and may be used and reprinted without permission; citation as to source, however, is appreciated.

                History
                Categories
                Full Report

                Comments

                Comment on this article